Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database.

about

Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database.

Item

http://www.wikidata.org/entity/Q48606842

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Management and cost analysis o ...... healthcare insurance database.

@en

Management and cost analysis o ...... healthcare insurance database.

@nl

type

Item

label

Management and cost analysis o ...... healthcare insurance database.

@en

Management and cost analysis o ...... healthcare insurance database.

@nl

prefLabel

Management and cost analysis o ...... healthcare insurance database.

@en

Management and cost analysis o ...... healthcare insurance database.

@nl

P1476

Management and cost analysis o ...... healthcare insurance database.

@en

P2093

Antoine Lafuma

http://www.w3.org/2001/XMLSchema#string

Corinne Emery

http://www.w3.org/2001/XMLSchema#string

Julie Gourmelen

http://www.w3.org/2001/XMLSchema#string

Patrick Tilleul

http://www.w3.org/2001/XMLSchema#string

William Jacot

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.

Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.

Impact of effective prevention and management of febrile neutropenia.

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database.

Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.

P304

1261-1267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2017.1366324

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28795868

http://www.w3.org/2001/XMLSchema#string

P921

Base de dados